Anavex Historical Balance Sheet

AVXL Stock

USD 7.91 0.06 0.76%

Trend analysis of Anavex Life Sciences balance sheet accounts such as Other Current Liab of 3.2 M, Total Current Liabilities of 18.5 M or Total Stockholder Equity of 145.2 M provides information on Anavex Life's total assets, liabilities, and equity, which is the actual value of Anavex Life Sciences to its prevalent stockholders. By breaking down trends over time using Anavex Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Anavex Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Anavex Life Sciences is a good buy for the upcoming year.

Anavex Life Inventory

15,464.93

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

About Anavex Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Anavex Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Anavex Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Anavex Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Anavex currently owns. An asset can also be divided into two categories, current and non-current.

Anavex Life Balance Sheet Chart

At this time, Anavex Life's Common Stock Total Equity is quite stable compared to the past year. Common Stock Shares Outstanding is expected to rise to about 100.8 M this year, although the value of Net Debt is projected to rise to (113 M).

Total Assets Other Current Liab Total Current Liabilities Cash And Short Term Investments Total Current Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of Anavex Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Anavex Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Anavex Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Anavex Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Anavex Life Sciences balance sheet. This account contains Anavex Life investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Anavex Life Sciences fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Most accounts from Anavex Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Anavex Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	8.2M	4.8M	5.6M	3.2M
Total Assets	154.4M	135.6M	155.9M	163.7M

Other Current Liab Total Assets

Anavex Life balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Long Term Debt Total	Other Current Assets	Short Term Debt	Property Plant And Equipment Net	Current Deferred Revenue	Property Plant And Equipment Gross	Non Current Liabilities Total	Net Receivables	Net Tangible Assets	Other Assets	Retained Earnings Total Equity
Total Assets		0.8	0.93	1.0	-0.98	-0.93	1.0	1.0	0.9	0.91	0.96	0.9	1.0	0.9	0.77	-0.24	0.18	-0.37	-0.09	0.58	-0.09	0.74	0.65	1.0	0.33	-0.92
Other Current Liab	0.8		0.68	0.81	-0.85	-0.78	0.8	0.8	0.74	0.75	0.74	0.63	0.8	0.72	0.46	-0.3	0.04	-0.22	-0.18	0.65	-0.18	0.65	0.51	0.77	0.35	-0.81
Total Current Liabilities	0.93	0.68		0.91	-0.86	-0.96	0.93	0.93	0.93	0.95	0.99	0.97	0.93	0.95	0.93	-0.27	0.3	-0.32	-0.1	0.67	-0.1	0.65	0.53	0.95	0.13	-0.89
Total Stockholder Equity	1.0	0.81	0.91		-0.99	-0.92	1.0	1.0	0.89	0.9	0.96	0.89	1.0	0.89	0.75	-0.25	0.17	-0.38	-0.11	0.56	-0.11	0.73	0.66	0.99	0.34	-0.92
Net Debt	-0.98	-0.85	-0.86	-0.99		0.91	-0.98	-0.98	-0.85	-0.87	-0.92	-0.83	-0.98	-0.85	-0.68	0.25	-0.15	0.37	0.12	-0.55	0.12	-0.75	-0.67	-0.97	-0.38	0.93
Retained Earnings	-0.93	-0.78	-0.96	-0.92	0.91		-0.93	-0.93	-0.93	-0.96	-0.98	-0.93	-0.93	-0.95	-0.86	0.25	-0.35	0.37	0.08	-0.71	0.08	-0.71	-0.54	-0.93	-0.23	0.96
Cash	1.0	0.8	0.93	1.0	-0.98	-0.93		1.0	0.9	0.91	0.97	0.9	1.0	0.9	0.77	-0.23	0.17	-0.37	-0.09	0.57	-0.09	0.74	0.63	1.0	0.33	-0.92
Cash And Short Term Investments	1.0	0.8	0.93	1.0	-0.98	-0.93	1.0		0.9	0.91	0.97	0.9	1.0	0.9	0.77	-0.23	0.17	-0.37	-0.09	0.57	-0.09	0.74	0.63	1.0	0.33	-0.92
Common Stock Total Equity	0.9	0.74	0.93	0.89	-0.85	-0.93	0.9	0.9		0.94	0.94	0.94	0.9	1.0	0.84	-0.09	0.34	-0.22	0.11	0.83	0.11	0.74	0.61	0.9	0.24	-0.91
Common Stock Shares Outstanding	0.91	0.75	0.95	0.9	-0.87	-0.96	0.91	0.91	0.94		0.96	0.9	0.91	0.94	0.88	-0.33	0.41	-0.48	-0.12	0.71	-0.12	0.6	0.59	0.92	0.23	-0.95
Other Stockholder Equity	0.96	0.74	0.99	0.96	-0.92	-0.98	0.97	0.97	0.94	0.96		0.96	0.96	0.96	0.89	-0.25	0.3	-0.38	-0.08	0.66	-0.08	0.69	0.55	0.98	0.23	-0.93
Total Liab	0.9	0.63	0.97	0.89	-0.83	-0.93	0.9	0.9	0.94	0.9	0.96		0.9	0.96	0.91	-0.03	0.26	-0.24	0.07	0.68	0.07	0.75	0.5	0.92	0.12	-0.86
Total Current Assets	1.0	0.8	0.93	1.0	-0.98	-0.93	1.0	1.0	0.9	0.91	0.96	0.9		0.9	0.77	-0.24	0.18	-0.37	-0.09	0.58	-0.09	0.74	0.65	1.0	0.33	-0.92
Common Stock	0.9	0.72	0.95	0.89	-0.85	-0.95	0.9	0.9	1.0	0.94	0.96	0.96	0.9		0.87	-0.1	0.34	-0.23	0.1	0.81	0.1	0.73	0.58	0.91	0.2	-0.91
Accounts Payable	0.77	0.46	0.93	0.75	-0.68	-0.86	0.77	0.77	0.84	0.88	0.89	0.91	0.77	0.87		-0.24	0.37	-0.39	0.0	0.65	0.0	0.45	0.36	0.81	-0.03	-0.76
Short Long Term Debt Total	-0.24	-0.3	-0.27	-0.25	0.25	0.25	-0.23	-0.23	-0.09	-0.33	-0.25	-0.03	-0.24	-0.1	-0.24		-0.19	0.37	0.6	-0.07	0.6	0.31	-0.21	-0.25	-0.07	0.27
Other Current Assets	0.18	0.04	0.3	0.17	-0.15	-0.35	0.17	0.17	0.34	0.41	0.3	0.26	0.18	0.34	0.37	-0.19		-0.29	-0.08	0.37	-0.08	0.05	0.17	0.19	-0.09	-0.36
Short Term Debt	-0.37	-0.22	-0.32	-0.38	0.37	0.37	-0.37	-0.37	-0.22	-0.48	-0.38	-0.24	-0.37	-0.23	-0.39	0.37	-0.29		0.2	0.08	0.2	-0.05	-0.28	-0.37	-0.09	0.5
Property Plant And Equipment Net	-0.09	-0.18	-0.1	-0.11	0.12	0.08	-0.09	-0.09	0.11	-0.12	-0.08	0.07	-0.09	0.1	0.0	0.6	-0.08	0.2		0.17	1.0	0.2	-0.11	-0.1	-0.04	0.06
Current Deferred Revenue	0.58	0.65	0.67	0.56	-0.55	-0.71	0.57	0.57	0.83	0.71	0.66	0.68	0.58	0.81	0.65	-0.07	0.37	0.08	0.17		0.17	0.47	0.34	0.58	0.06	-0.64
Property Plant And Equipment Gross	-0.09	-0.18	-0.1	-0.11	0.12	0.08	-0.09	-0.09	0.11	-0.12	-0.08	0.07	-0.09	0.1	0.0	0.6	-0.08	0.2	1.0	0.17		0.2	-0.11	-0.1	-0.04	0.06
Non Current Liabilities Total	0.74	0.65	0.65	0.73	-0.75	-0.71	0.74	0.74	0.74	0.6	0.69	0.75	0.74	0.73	0.45	0.31	0.05	-0.05	0.2	0.47	0.2		0.6	0.71	0.17	-0.71
Net Receivables	0.65	0.51	0.53	0.66	-0.67	-0.54	0.63	0.63	0.61	0.59	0.55	0.5	0.65	0.58	0.36	-0.21	0.17	-0.28	-0.11	0.34	-0.11	0.6		0.62	0.14	-0.64
Net Tangible Assets	1.0	0.77	0.95	0.99	-0.97	-0.93	1.0	1.0	0.9	0.92	0.98	0.92	1.0	0.91	0.81	-0.25	0.19	-0.37	-0.1	0.58	-0.1	0.71	0.62		0.29	-0.92
Other Assets	0.33	0.35	0.13	0.34	-0.38	-0.23	0.33	0.33	0.24	0.23	0.23	0.12	0.33	0.2	-0.03	-0.07	-0.09	-0.09	-0.04	0.06	-0.04	0.17	0.14	0.29		-0.35
Retained Earnings Total Equity	-0.92	-0.81	-0.89	-0.92	0.93	0.96	-0.92	-0.92	-0.91	-0.95	-0.93	-0.86	-0.92	-0.91	-0.76	0.27	-0.36	0.5	0.06	-0.64	0.06	-0.71	-0.64	-0.92	-0.35

Click cells to compare fundamentals

Anavex Life Account Relationship Matchups

Anavex Life balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	161.6M	152.7M	154.4M	135.6M	155.9M	163.7M
Other Current Liab	5.6M	6.4M	8.2M	4.8M	5.6M	3.2M
Total Current Liabilities	10.8M	10.2M	12.5M	15.3M	17.6M	18.5M
Total Stockholder Equity	150.8M	142.5M	141.9M	120.3M	138.3M	145.2M
Net Debt	(152.1M)	(149.2M)	(151.0M)	(132.2M)	(119.0M)	(113.0M)
Retained Earnings	(197.6M)	(245.6M)	(293.1M)	(336.1M)	(302.5M)	(287.3M)
Cash	152.1M	149.2M	151.0M	132.2M	152.0M	159.6M
Cash And Short Term Investments	152.1M	149.2M	151.0M	132.2M	152.0M	159.6M
Common Stock Total Equity	52.7K	62.0K	75.9K	77.9K	89.6K	94.1K
Common Stock Shares Outstanding	69.8M	76.9M	79.8M	83.5M	96.0M	100.8M
Liabilities And Stockholders Equity	161.6M	152.7M	154.4M	135.6M	155.9M	163.7M
Other Stockholder Equity	348.3M	388.0M	434.8M	456.2M	524.7M	550.9M
Total Liab	10.8M	10.2M	12.5M	15.3M	17.6M	18.5M
Total Current Assets	161.6M	152.7M	154.4M	135.6M	155.9M	163.7M
Common Stock	75.9K	77.9K	82K	85K	97.8K	102.6K
Accounts Payable	4.7M	3.8M	4.3M	9.6M	11.1M	11.6M
Other Current Assets	371.9K	354K	653K	931K	1.1M	1.1M
Non Current Liabilities Total	5.6M	4.3M	7.3M	4.8M	5.6M	2.8M
Net Receivables	9.1M	3.2M	2.7M	2.4M	2.8M	2.1M
Net Tangible Assets	27.2M	150.8M	142.5M	141.9M	163.1M	171.3M
Other Assets	(16.4K)	3.5B	3.4M	3.4M	3.9M	3.7M
Retained Earnings Total Equity	(133.4M)	(159.7M)	(197.6M)	(245.6M)	(221.0M)	(210.0M)
Capital Surpluse	153.6M	186.9M	348.3M	388.0M	446.2M	468.5M
Net Invested Capital	150.8M	142.5M	141.9M	120.3M	138.3M	89.1M
Net Working Capital	150.8M	142.5M	141.9M	120.3M	138.3M	89.0M
Capital Stock	75.9K	77.9K	82K	85K	97.8K	75.7K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:

How To Invest In Anavex

Details

Is Anavex Stock a good investment?

Details

What is Anavex Life's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.55)

Return On Assets

(0.24)

Return On Equity

(0.38)

The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Anavex Historical Balance Sheet

Anavex Life Inventory

15,464.93

About Anavex Balance Sheet Analysis

Anavex Life Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash And Short Term Investments

Total Current Assets

Anavex Life balance sheet Correlations

Anavex Life Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Anavex Life balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Cash	+ 1.0	Total Stockholder Equity

Net Debt	- 0.99	Total Stockholder Equity
Other Stockholder Equity	- 0.98	Retained Earnings
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Net Debt	- 0.98	Total Assets